Login

Anders Rabbe, CEO, Isofol Medical AB (publ) 00:00:00

Share On Facebook Share On Twitter

Isofol Medical at Pareto Securities' Health Care Conference

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exclusive Insight: A Conversation with Ng Chai Yong, CEO of Mah Sing
00:00:00
Proteomics International focused on first commercial sales for PromarkerD in USA - Dr Richard Lipscombe, MD, Proteomics International Laboratories Ltd
00:10:00
Nordic Real Estate Acquisition Discussed by CEO | Erik Selin, CEO, Fastighets AB Balder.
00:10:00
Invests in today’s most promising energy innovators and works with the world’s leading energy companies|Jason Blumberg,Co-Founder and Managing Director,Energy Foundry
00:10:00
A Special Update from Klaas Financial CEO Maleeah Cuevas| Maleeah Cuevas, CEO, Klaas Financial.
00:10:00
Deciphering the Market: Insights from Jeffrey Gundlach on Current Economic Signals | Jeffrey Gundlach, CEO , DoubleLine Capital.
00:10:00
Meet the Manager: Ian Heslop, Head of Global Equities at Old Mutual Investors
00:10:00
Strategic Insights on the Edelweiss Greater China Fund | Radhika Gupta - MD & CEO, Edelweiss Mutual Fund
00:10:00
Inside the Minds of Wall Street's Titans: Insights and Predictions from Global Alts 2024
00:10:00
Pushing RNA Interference Beyond Liver Diseases and into Diverse Therapeutic Areas |Christopher Richard Anzalone, CEO, Arrowhead Pharmaceuticals Inc.
00:10:00
Osisko Metals CEO Discusses Major Project Updates and Positive Outlook for Copper Market
00:10:00
Investing in Cribl: A $2.45 Billion Data Analytics Startup|Max Gazor,investor,CRV

© 2017 - Neuhu+